Quantcast
Last updated on April 18, 2014 at 10:16 EDT

Latest Organ failure Stories

2013-04-12 12:00:19

Differences are especially pronounced in regions that spend the most on end-of-life care Highlights: -There is substantial regional variation in the magnitude of racial differences in end-of-life care among US adults with kidney failure. -Black-white differences in dialysis discontinuation and hospice referral are most pronounced in regions with the highest levels of end-of-life spending. More than 590,000 Americans in 2010 were treated for kidney failure. At the end of life,...

2013-04-11 08:29:18

SUNNYVALE, Calif., April 11, 2013 /PRNewswire/ -- Sorbent Therapeutics, Inc., a biopharmaceutical company developing therapies for cardiovascular and renal diseases, today announced that patient dosing has commenced in its Phase 2b clinical trial of CLP-1001. This trial, known as STEPWISE (a randomized, double-blind, multi-center STudy comparing cross-linkEd Polyelectrolyte (CLP) WIth placebo in HF SubjEcts), is designed to evaluate the safety and efficacy of CLP-1001 in addressing signs and...

2013-04-10 08:31:11

Galectin-3 test may help physicians identify patients at highest risk for a worse prognosis, including re-hospitalization and death, allowing them to tailor the level of care to individual patient needs1 ABBOTT PARK, Ill., April 10, 2013 /PRNewswire/ -- Abbott today announced CE Marking (Conformite Europeenne) for the ARCHITECT Galectin-3 assay, a test to aid doctors in assessing the prognosis of patients diagnosed with chronic heart failure (HF). The test was developed in...

2013-04-05 12:06:55

Additional studies are needed to determine benefits and risks of treatment Highlights: -Growth hormone therapy can help reverse growth problems in children with kidney failure. -Growth hormone therapy increases bone turnover in children on dialysis -Additional studies are needed to evaluate the impact of growth hormone therapy on final height, fracture risk, bone deformities, and puberty in children with kidney failure. -Growth failure occurs early in chronic kidney disease and...

2013-04-05 11:55:15

Avoiding excess weight gain could prevent many cases of chronic kidney disease Highlights: Individuals who are overweight starting in early adulthood are twice as likely to have chronic kidney disease at age 60 to 64 years than those who are not overweight. Larger waist-to-hip ratios ("apple-shaped" bodies) during middle age are also linked with chronic kidney disease at age 60 to 64 years. More than one-third of chronic kidney disease cases at age 60 to 64 years in the US could...

2013-04-04 12:25:14

EXTON, Pa., April 4, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, compared to just one year ago, the mean hemoglobin at erythropoiesis-stimulating agent (ESA) initiation has significantly declined and is nearing levels at which a blood transfusion may be required. In addition, nephrologists tend to overestimate the percent of stage 3 chronic kidney disease (CKD) patients on an ESA,...

Lifetime Risks For Heart Failure Similar In Both White And Black Races
2013-04-03 06:33:27

Lawrence LeBlond for redOrbit.com - Your Universe Online A new study from researchers at Northwestern University has found that lifetime risk for heart failure is similar for blacks and whites. The study also found that in both races the risks were higher than expected, ranging from 20 to 45 percent. The research, which is published online this week in the Journal of the American College of Cardiology (JACC), is the first to explore the long-term risk of heart failure in different race...

2013-03-29 08:22:29

SAN DIEGO, March 29, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that Krisztina Zsebo Ph.D., President and Chief Executive Officer will present an overview of the company at the 2013 BioCentury Future Leaders in the Biotech Industry Conference. The presentation will take place at the Millennium Broadway Hotel & Conference Center in New York City, on...

2013-03-22 15:16:08

Tests of resistance could help doctors monitor and treat patients Highlights: -Suboptimal kidney response to the hormone FGF-23 may put chronic kidney disease patients at increased risk of premature death and cardiovascular events. -Resistance to the hormonal actions of FGF-23 in the kidney may identify novel aspects of kidney dysfunction. -60 million people globally have chronic kidney disease. The kidneys' response to a particular hormone may affect kidney disease patients' heart...

2013-03-19 08:27:45

COLUMBUS, Ohio, March 19, 2013 /PRNewswire/ -- Columbus Regional Hospital was recognized today as the first community based independent hospital to achieve Heart Failure Center Re-accreditation by the Healthcare Accreditation Colloquium in 2013. The Colloquium has pioneered "continual accreditation" which requires hospitals to add additional heart failure services for their communities each year. Columbus Regional Hospital has launched a new effort at reducing sudden cardiac death for those...